PubMed for id: 1890270703

Year	Number of Results
1993	1
1994	1
1995	1
1996	1
1997	1
2001	1
2015	1
2016	1
2022	1
2023	1
2024	0

1

Neuroblastoma suppressor of tumorigenicity 1 is associated with the severity of interstitial fibrosis and kidney function decline in IgA nephropathy.

Kobayashi H, Satake E, Murata Y, Otsuka H, Tsunemi A, Azuma M, Nakamura Y, Saito T, Abe M. Kobayashi H, et al. J Nephrol. 2023 Nov;36(8):2245-2256. doi: 10.1007/s40620-023-01704-x. Epub 2023 Jul 12. J Nephrol. 2023. PMID: 37436574

2

Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes.

Kobayashi H, Looker HC, Satake E, D'Addio F, Wilson JM, Saulnier PJ, Md Dom ZI, O'Neil K, Ihara K, Krolewski B, Badger HS, Petrazzuolo A, Corradi D, Galecki A, Wilson PC, Najafian B, Mauer M, Niewczas MA, Doria A, Humphreys BD, Duffin KL, Fiorina P, Nelson RG, Krolewski AS. Kobayashi H, et al. Sci Transl Med. 2022 Aug 10;14(657):eabj2109. doi: 10.1126/scitranslmed.abj2109. Epub 2022 Aug 10. Sci Transl Med. 2022. PMID: 35947673 Free PMC article.

3

Structure of Gremlin-2 in Complex with GDF5 Gives Insight into DAN-Family-Mediated BMP Antagonism.

Nolan K, Kattamuri C, Rankin SA, Read RJ, Zorn AM, Thompson TB. Nolan K, et al. Cell Rep. 2016 Aug 23;16(8):2077-2086. doi: 10.1016/j.celrep.2016.07.046. Epub 2016 Aug 11. Cell Rep. 2016. PMID: 27524626 Free PMC article.

4

Structure of neuroblastoma suppressor of tumorigenicity 1 (NBL1): insights for the functional variability across bone morphogenetic protein (BMP) antagonists.

Nolan K, Kattamuri C, Luedeke DM, Angerman EB, Rankin SA, Stevens ML, Zorn AM, Thompson TB. Nolan K, et al. J Biol Chem. 2015 Feb 20;290(8):4759-4771. doi: 10.1074/jbc.M114.628412. Epub 2015 Jan 5. J Biol Chem. 2015. PMID: 25561725 Free PMC article.

5

Purification and partial amino acid sequence of proteins from human epidermal keratinocyte conditioned medium.

Ahmed A, Kandola P, Ziada G, Parenteau N. Ahmed A, et al. J Protein Chem. 2001 May;20(4):273-8. doi: 10.1023/a:1010902815953. J Protein Chem. 2001. PMID: 11594460

6

The genomic analysis of human DAN gene.

Ozaki T, Enomoto H, Nakamura Y, Kondo K, Seki N, Ohira M, Nomura N, Ohki M, Nakagawara A, Sakiyama S. Ozaki T, et al. DNA Cell Biol. 1997 Sep;16(9):1031-9. doi: 10.1089/dna.1997.16.1031. DNA Cell Biol. 1997. PMID: 9324305

7

Cloning of mouse DAN cDNA and its down-regulation in transformed cells.

Ozaki T, Ma J, Takenaga K, Sakiyama S. Ozaki T, et al. Jpn J Cancer Res. 1996 Jan;87(1):58-61. doi: 10.1111/j.1349-7006.1996.tb00200.x. Jpn J Cancer Res. 1996. PMID: 8609050 Free PMC article.

8

Molecular cloning and characterization of a cDNA showing negative regulation in v-src-transformed 3Y1 rat fibroblasts.

Ozaki T, Sakiyama S. Ozaki T, et al. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2593-7. doi: 10.1073/pnas.90.7.2593. Proc Natl Acad Sci U S A. 1993. PMID: 8385338 Free PMC article.

9

Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus.

Enomoto H, Ozaki T, Takahashi E, Nomura N, Tabata S, Takahashi H, Ohnuma N, Tanabe M, Iwai J, Yoshida H, et al. Enomoto H, et al. Oncogene. 1994 Oct;9(10):2785-91. Oncogene. 1994. PMID: 8084583

10

A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3.

White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C, Valentine MB, Look AT, Enomoto H, Sakiyama S, Brodeur GM. White PS, et al. Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5520-4. doi: 10.1073/pnas.92.12.5520. Proc Natl Acad Sci U S A. 1995. PMID: 7777541 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year